ID

13475

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Mots-clés

  1. 05/03/2015 05/03/2015 -
  2. 09/03/2015 09/03/2015 -
  3. 24/04/2015 24/04/2015 -
  4. 15/12/2015 15/12/2015 -
  5. 11/02/2016 11/02/2016 -
Téléchargé le

11 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

End of Study AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

End of Study
Description

End of Study

End of Study Date
Description

End of Study Date

Type de données

date

Alias
UMLS CUI-1
C2983670
Reason for End of Study
Description

Reason for End of Study

Type de données

integer

Alias
UMLS CUI-1
C2348577
Specify if Reason for End of Study = 6 or 7
Description

Specify if Reason for End of Study = 6 or 7

Type de données

text

Alias
UMLS CUI [1]
C1521902
Induction therapy I administered
Description

Induction therapy I administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Induction therapy II administered
Description

Induction therapy II administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy I administered
Description

Consolidation therapy I administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Consolidation therapy II administered
Description

Consolidation therapy II administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy III administered
Description

Consolidation therapy III administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205449
Consolidation therapy IV administered
Description

Consolidation therapy IV administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205450
Maintenance therapy administered
Description

Maintenance therapy administered

Type de données

boolean

Alias
UMLS CUI [1,1]
C0481504
UMLS CUI [1,2]
C0806914
Signature
Description

Signature

Date
Description

Date

Type de données

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Description

Name of Investigator

Type de données

text

Alias
UMLS CUI-1
C2826892
Signature of investigator
Description

Signature of investigator

Type de données

text

Alias
UMLS CUI-1
C2346576

Similar models

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
End of Study
End of Study Date
Item
End of Study Date
date
C2983670 (UMLS CUI-1)
Item
Reason for End of Study
integer
C2348577 (UMLS CUI-1)
Code List
Reason for End of Study
CL Item
regular End of Study (0)
C0205272 (UMLS CUI-1)
CL Item
no CR after Induction (Progressive Disease) (1)
C1335499 (UMLS CUI-1)
CL Item
exzessive extramedullary medical toxicity (2)
C0013221 (UMLS CUI-1)
CL Item
death (3)
C0021430 (UMLS CUI-1)
CL Item
relapse after CR (4)
C0035020 (UMLS CUI-1)
CL Item
Withdrawal of informed consent (5)
C0021430 (UMLS CUI-1)
C1710677 (UMLS CUI-2)
CL Item
Protocol deviation (6)
C1705236 (UMLS CUI-1)
CL Item
other (7)
C0205394 (UMLS CUI-1)
Specify if Reason for End of Study = 6 or 7
Item
Specify if Reason for End of Study = 6 or 7
text
C1521902 (UMLS CUI [1])
Induction therapy I administered
Item
Induction therapy I administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Induction therapy II administered
Item
Induction therapy II administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy I administered
Item
Consolidation therapy I administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Consolidation therapy II administered
Item
Consolidation therapy II administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy III administered
Item
Consolidation therapy III administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205449 (UMLS CUI [1,3])
Consolidation therapy IV administered
Item
Consolidation therapy IV administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205450 (UMLS CUI [1,3])
Maintenance therapy administered
Item
Maintenance therapy administered
boolean
C0481504 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial